Open AccessA Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia
Author(s) -
Laura K. Beres,
Jacqueline E. Tate,
Lungowe Njobvu,
Bertha Chibwe,
Cheryl Rudd,
M. Brad Guffey,
Jeffrey S. A. Stringer,
Umesh D. Parashar,
Roma Chilengi
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ1206
Subject(s) - medicine , rotavirus vaccine , rotavirus , virology , rotavirus infections , virus
Diarrhea is the third leading cause of child death in Zambia. Up to one-third of diarrhea cases resulting in hospitalization and/or death are caused by vaccine-preventable rotavirus. In January 2012, Zambia initiated a pilot introduction of the Rotarix live, oral rotavirus vaccine in all public health facilities in Lusaka Province.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom